Chemobrain: is systemic chemotherapy neurotoxic?

Area of Science:

• Neuroscience
• Oncology
• Pharmacology

Background:

• Chemobrain, or chemotherapy-induced cognitive dysfunction, is widely acknowledged but poorly understood.
• Inconsistent data exists regarding the types, duration, and causes of cognitive impairment.
• Key factors like responsible agents, patient vulnerability, and biological mechanisms require further investigation.

Purpose of the Study:

• To provide an updated definition of chemobrain, incorporating recent functional imaging data.
• To discuss controversial aspects and potential causes, such as oxidative stress.
• To propose improvements for future clinical trial design and methodology.

Main Methods:

• Comprehensive review of recent scientific literature on chemobrain.
• Analysis of functional imaging data related to chemotherapy-induced cognitive changes.
• Critical evaluation of methodological approaches in existing studies.

Main Results:

• An updated definition of chemobrain is presented, alongside a discussion of its contentious elements.
• Oxidative stress is identified as a potential contributing factor, with implications for prevention and treatment.
• Methodological limitations in current research are highlighted, with recommendations for future studies.

Conclusions:

• Chemobrain is a clinically significant issue due to rising cancer survival rates and aggressive chemotherapy use.
• Improved trial design is crucial for a clearer understanding and effective management of chemobrain.
• Future research should focus on elucidating mechanisms and developing targeted therapies.